Oncology Institute (TOIIW) Competitors $0.08 -0.01 (-13.78%) Closing price 05/21/2025 03:40 PM EasternExtended Trading$0.07 -0.01 (-12.37%) As of 05/21/2025 05:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock TOIIW vs. ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, NTRA, FMS, and HIMSShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Oncology Institute vs. Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Natera Fresenius Medical Care Hims & Hers Health Oncology Institute (NASDAQ:TOIIW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, community ranking, risk, institutional ownership and valuation. Which has better earnings & valuation, TOIIW or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$393.41MN/AN/AN/AN/AAclarion$45.72KN/AN/AN/AN/A Is TOIIW or ACONW more profitable? Company Net Margins Return on Equity Return on Assets Oncology InstituteN/A N/A N/A Aclarion N/A N/A N/A Does the MarketBeat Community prefer TOIIW or ACONW? Oncology Institute and Aclarion both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformOncology InstituteN/AN/AAclarionN/AN/A Does the media favor TOIIW or ACONW? In the previous week, Oncology Institute had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for Oncology Institute and 0 mentions for Aclarion. Oncology Institute's average media sentiment score of 0.54 beat Aclarion's score of 0.00 indicating that Oncology Institute is being referred to more favorably in the media. Company Overall Sentiment Oncology Institute Positive Aclarion Neutral SummaryOncology Institute beats Aclarion on 3 of the 3 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOIIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOIIW vs. The Competition Export to ExcelMetricOncology InstituteMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.69B$5.35B$8.38BDividend YieldN/A3.83%5.22%4.10%P/E RatioN/A7.2326.8419.71Price / SalesN/A12.86391.39116.98Price / CashN/A12.5138.2534.62Price / BookN/A1.996.794.50Net IncomeN/A$58.65M$3.23B$248.18M7 Day PerformanceN/A20.79%4.07%1.14%1 Month PerformanceN/A164.81%12.52%15.20%1 Year PerformanceN/A12.61%16.83%6.56% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIIWOncology InstituteN/A$0.08-13.8%N/A-22.2%$0.00$393.41M0.00660Positive NewsHigh Trading VolumeACONWAclarionN/A$0.03-18.9%N/A+23.0%$0.00$45,724.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$6.00+2.6%N/A+258.8%$0.00$1.34B0.001,520Gap UpDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/AGap UpLFMDPLifeMDN/A$24.34-0.3%N/A+16.5%$0.00$234.01M0.00230OTRKPOntrakN/A$0.22-2.2%N/A-26.7%$0.00$10.84M0.00250News CoveragePositive NewsGap DownPIIIWP3 Health PartnersN/A$0.01-22.4%N/A-82.6%$0.00$1.50B0.00500Positive NewsGap UpHigh Trading VolumeTALKWTalkspaceN/A$0.12+8.4%N/A-33.1%$0.00$194.36M0.00500High Trading VolumeNTRANatera3.2652 of 5 stars$151.07-0.8%$181.82+20.4%+39.6%$20.42B$1.83B-85.843,020Positive NewsFMSFresenius Medical Care3.1432 of 5 stars$27.86-0.5%$27.80-0.2%+39.1%$16.35B$19.49B23.02123,200Positive NewsAnalyst ForecastGap UpHIMSHims & Hers Health2.3602 of 5 stars$61.52-3.9%$37.67-38.8%+229.9%$13.77B$1.78B139.82650Trending NewsInsider Trade Related Companies and Tools Related Companies ACONW Alternatives AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOIIW) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
